DCGI extends drug imports deadline on shelf-life rule
The Hindu
With the existing deadline till October 31, the latest extension is for six months
The Drugs Controller General of India (DCGI) has extended till April 30 the deadline for allowing import of drugs with residual shelf life less than 60%.
Sharing the DCGI notification with its members, Pharmaceuticals Export Promotion Council of India (Pharmexcil) said import of drugs with less than 60% residual shelf life was being permitted since April 2020. It followed representations from the importers citing delay in clearances at port offices close on the heels of the COVID-19 outbreak. With the existing deadline till October 31, the latest extension is for six months.
Under the Drugs and Cosmetics Act 1945, import of a drug with less than 60% residual shelf life, as on the date of import, should not be permitted by the licensing authority. In exceptional cases, however, the authority can allow import of any drug with a lesser shelf life, but before its expiry date.
According to BACL, the biophilic-inspired business park will offer smart workspaces within a vibrant public realm. The project’s most exceptional and breathtaking attribute lies in the Urban Forest, a lush oasis in the centre of the development. This green space will serve as a focal point, seamlessly blending indoor and outdoor spaces throughout the area. The upcoming metro station in Airport City will provide seamless connectivity to the business park from the northern side, ensuring convenient accessibility.